DEL PRATO, STEFANO Statistiche
DEL PRATO, STEFANO
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
2025-01-01 Dinoi, Elisa; Daniele, Giuseppe; Michelucci, Angela; Baldinotti, Fulvia; Campi, Fabrizio; Marchetti, Piero; Del Prato, Stefano; Dardano, Angela
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care
2024-01-01 Fadini, Gian Paolo; Longato, Enrico; Morieri, Mario Luca; Bonora, Enzo; Consoli, Agostino; Fattor, Bruno; Rigato, Mauro; Turchi, Federica; Del Prato, Stefano; Avogaro, Angelo; Solini, Anna; Null, Null
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
2024-01-01 Garofolo, Monia; Lucchesi, Daniela; Giambalvo, Massimo; Aragona, Michele; Bertolotto, Alessandra; Campi, Fabrizio; Bianchi, Cristina; Francesconi, Paolo; Marchetti, Piero; Del Prato, Stefano; Penno, Giuseppe
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
2024-01-01 Ciardullo, Stefano; Morieri, Mario Luca; Daniele, Giuseppe; Fiorentino, Teresa Vanessa; Mezza, Teresa; Tricò, Domenico; Consoli, Agostino; Del Prato, Stefano; Giorgino, Francesco; Piro, Salvatore; Solini, Anna; Avogaro, Angelo
The current landscape for diabetes treatment: Preventing diabetes-associated CV risk
2024-01-01 Dardano, Angela; Bianchi, Cristina; Garofolo, Monia; Del Prato, Stefano
β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
2024-01-01 Daniele, Giuseppe; Tura, Andrea; Brocchi, Alex; Saba, Alessandro; Campi, Beatrice; Sancho-Bornez, Veronica; Dardano, Angela; Del Prato, Stefano
An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
2023-01-01 Lucchesi, Daniela; Randazzo, Emioli; Del Prato, Stefano; Bianchi, Cristina
De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes
2023-01-01 Falcetta, Pierpaolo; Nicolì, Francesca; Citro, Fabrizia; Ciccarone, Annamaria; Garofolo, Monia; Del Prato, Stefano; Bianchi, Cristina
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
2023-01-01 Abdelgani, Siham; Khattab, Ahmed; Adams, John; Abu-Farha, Mohamed; Daniele, Giuseppe; Al-Mulla, Fahd; Del Prato, Stefano; Defronzo, Ralph A; Abdul-Ghani, Muhammad
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
2023-01-01 Solini, Anna; Tricò, Domenico; Del Prato, Stefano
Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease
2023-01-01 Garofolo, Monia; Napoli, Vinicio; Lucchesi, Daniela; Accogli, Sandra; Mazzeo, Maria Letizia; Rossi, Piercarlo; Neri, Emanuele; Del Prato, Stefano; Penno, Giuseppe
Basal weekly insulins: the way of the future!
2022-01-01 Rosenstock, J.; Del Prato, S.
Brain effect of bariatric surgery in people with obesity
2022-01-01 Dardano, A; Aghakhanyan, G; Moretto, C; Ciccarone, A; Bellini, R; Sancho Bornez, V; Ceccarini, G; Santini, F; Volterrani, D; Del Prato, S; Daniele, G.
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report
2022-01-01 Dardano, Angela; Aragona, Michele; Daniele, Giuseppe; Miccoli, Roberto; Del Prato, Stefano
Insulin discovery: A pivotal point in medical history
2022-01-01 Falcetta, P.; Aragona, M.; Bertolotto, A.; Bianchi, C.; Campi, F.; Garofolo, M.; Del Prato, S.
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance
2022-01-01 Dimova, Rumyana; Chakarova, Nevena; Daniele, Giuseppe; Bianchi, Cristina; Dardano, Angela; Del Prato, Stefano; Tankova, Tsvetalina
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance
2022-01-01 Bianchi, C.; Raggi, F.; Rossi, C.; Frontoni, S.; Bonadonna, R. C.; Del Prato, S.; Solini, A.
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study
2022-01-01 Dardano, Angela; Lucchesi, Daniela; Garofolo, Monia; Gualdani, Elisa; Falcetta, Pierpaolo; Sancho Bornez, Veronica; Francesconi, Paolo; Del Prato, Stefano; Penno, Giuseppe
The IGFBP3/TMEM219 pathway regulates beta cell homeostasis
2022-01-01 D'Addio, F.; Maestroni, A.; Assi, E.; Ben Nasr, M.; Amabile, G.; Usuelli, V.; Loretelli, C.; Bertuzzi, F.; Antonioli, B.; Cardarelli, F.; El Essawy, B.; Solini, A.; Gerling, I. C.; Bianchi, C.; Becchi, G.; Mazzucchelli, S.; Corradi, D.; Fadini, G. P.; Foschi, D.; Markmann, J. F.; Orsi, E.; Skrha, J.; Camboni, M. G.; Abdi, R.; James Shapiro, A. M.; Folli, F.; Ludvigsson, J.; Del Prato, S.; Zuccotti, G.; Fiorina, P.
The incretin/glucagon system as a target for pharmacotherapy of obesity
2022-01-01 Del Prato, S.; Gallwitz, B.; Holst, J. J.; Meier, J. J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report | 1-gen-2025 | Dinoi, Elisa; Daniele, Giuseppe; Michelucci, Angela; Baldinotti, Fulvia; Campi, Fabrizio; Marchetti, Piero; Del Prato, Stefano; Dardano, Angela | |
| Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care | 1-gen-2024 | Fadini, Gian Paolo; Longato, Enrico; Morieri, Mario Luca; Bonora, Enzo; Consoli, Agostino; Fattor, Bruno; Rigato, Mauro; Turchi, Federica; Del Prato, Stefano; Avogaro, Angelo; Solini, Anna; Null, Null | |
| Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study | 1-gen-2024 | Garofolo, Monia; Lucchesi, Daniela; Giambalvo, Massimo; Aragona, Michele; Bertolotto, Alessandra; Campi, Fabrizio; Bianchi, Cristina; Francesconi, Paolo; Marchetti, Piero; Del Prato, Stefano; Penno, Giuseppe | |
| GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | 1-gen-2024 | Ciardullo, Stefano; Morieri, Mario Luca; Daniele, Giuseppe; Fiorentino, Teresa Vanessa; Mezza, Teresa; Tricò, Domenico; Consoli, Agostino; Del Prato, Stefano; Giorgino, Francesco; Piro, Salvatore; Solini, Anna; Avogaro, Angelo | |
| The current landscape for diabetes treatment: Preventing diabetes-associated CV risk | 1-gen-2024 | Dardano, Angela; Bianchi, Cristina; Garofolo, Monia; Del Prato, Stefano | |
| β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin | 1-gen-2024 | Daniele, Giuseppe; Tura, Andrea; Brocchi, Alex; Saba, Alessandro; Campi, Beatrice; Sancho-Bornez, Veronica; Dardano, Angela; Del Prato, Stefano | |
| An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY? | 1-gen-2023 | Lucchesi, Daniela; Randazzo, Emioli; Del Prato, Stefano; Bianchi, Cristina | |
| De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes | 1-gen-2023 | Falcetta, Pierpaolo; Nicolì, Francesca; Citro, Fabrizia; Ciccarone, Annamaria; Garofolo, Monia; Del Prato, Stefano; Bianchi, Cristina | |
| Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients | 1-gen-2023 | Abdelgani, Siham; Khattab, Ahmed; Adams, John; Abu-Farha, Mohamed; Daniele, Giuseppe; Al-Mulla, Fahd; Del Prato, Stefano; Defronzo, Ralph A; Abdul-Ghani, Muhammad | |
| Incretins and cardiovascular disease: to the heart of type 2 diabetes? | 1-gen-2023 | Solini, Anna; Tricò, Domenico; Del Prato, Stefano | |
| Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease | 1-gen-2023 | Garofolo, Monia; Napoli, Vinicio; Lucchesi, Daniela; Accogli, Sandra; Mazzeo, Maria Letizia; Rossi, Piercarlo; Neri, Emanuele; Del Prato, Stefano; Penno, Giuseppe | |
| Basal weekly insulins: the way of the future! | 1-gen-2022 | Rosenstock, J.; Del Prato, S. | |
| Brain effect of bariatric surgery in people with obesity | 1-gen-2022 | Dardano, A; Aghakhanyan, G; Moretto, C; Ciccarone, A; Bellini, R; Sancho Bornez, V; Ceccarini, G; Santini, F; Volterrani, D; Del Prato, S; Daniele, G. | |
| Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report | 1-gen-2022 | Dardano, Angela; Aragona, Michele; Daniele, Giuseppe; Miccoli, Roberto; Del Prato, Stefano | |
| Insulin discovery: A pivotal point in medical history | 1-gen-2022 | Falcetta, P.; Aragona, M.; Bertolotto, A.; Bianchi, C.; Campi, F.; Garofolo, M.; Del Prato, S. | |
| Insulin secretion and action affect glucose variability in the early stages of glucose intolerance | 1-gen-2022 | Dimova, Rumyana; Chakarova, Nevena; Daniele, Giuseppe; Bianchi, Cristina; Dardano, Angela; Del Prato, Stefano; Tankova, Tsvetalina | |
| MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance | 1-gen-2022 | Bianchi, C.; Raggi, F.; Rossi, C.; Frontoni, S.; Bonadonna, R. C.; Del Prato, S.; Solini, A. | |
| SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study | 1-gen-2022 | Dardano, Angela; Lucchesi, Daniela; Garofolo, Monia; Gualdani, Elisa; Falcetta, Pierpaolo; Sancho Bornez, Veronica; Francesconi, Paolo; Del Prato, Stefano; Penno, Giuseppe | |
| The IGFBP3/TMEM219 pathway regulates beta cell homeostasis | 1-gen-2022 | D'Addio, F.; Maestroni, A.; Assi, E.; Ben Nasr, M.; Amabile, G.; Usuelli, V.; Loretelli, C.; Bertuzzi, F.; Antonioli, B.; Cardarelli, F.; El Essawy, B.; Solini, A.; Gerling, I. C.; Bianchi, C.; Becchi, G.; Mazzucchelli, S.; Corradi, D.; Fadini, G. P.; Foschi, D.; Markmann, J. F.; Orsi, E.; Skrha, J.; Camboni, M. G.; Abdi, R.; James Shapiro, A. M.; Folli, F.; Ludvigsson, J.; Del Prato, S.; Zuccotti, G.; Fiorina, P. | |
| The incretin/glucagon system as a target for pharmacotherapy of obesity | 1-gen-2022 | Del Prato, S.; Gallwitz, B.; Holst, J. J.; Meier, J. J. |